CRISPR-Based Detection Sparks Interest in the Influenza Diagnostics Market The global influenza diagnostics market was valued at USD 1.6 billion in 2023 and is projected to reach USD 2.4 billion by 2030, expanding at a 5.8% CAGR from 2024 to 2030. The market is expected to increase from USD 1.9 billion in 2026 to USD 2.4 billion by 2030. North America held the leading position in 2023, accounting for 32.7% of global revenue.
Annual influenza outbreaks continue to...
0 Shares
71 Views
0 Reviews